Cardioplegic Solution Injection, Solution
Product Images NDC 65219-258

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cardioplegic Solution (NDC 65219-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi, Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Freeflex Logo (Ple02 0003 01)

FDA Label Image

Fresenius Kabi Logo (Ple02 0003 02)

FDA Label Image

Freeflex Logo (Ple02 0003 03)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Cardioplegic Solution for Cardiac Perfusion 1000 mL Bag Label)

This is a description of a cardioplegic solution for cardiac perfusion called Free Flex. It comes in a 1000 mL container and contains various electrolytes such as Sodium, Calcium, Magnesium and Potassium, as well as warnings. Sodium Bicarbonate Injection, USP is required to adjust the pH before usage. The label on the flexible container has to be covered by an additional label where additives are mixed thoroughly with the solution. The container is made in Germany by Fresenius Kabi and its usual dosage is to be verified by the package insert.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Cardioplegic Solution Additive Label)

This is a description of an additive label for a cardioplegic solution. The solution contains electrolytes, including sodium, potassium, magnesium, calcium, chloride, and bicarbonate, with an osmolality of 324 mOsmol/liter and a pH of approximately 7.8 at room temperature. The label warns that the solution is not for intravenous injection and gives instructions for proper storage and use. The product is manufactured by Fresenius in Germany.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.